Clinical Trial Update: Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment

View source ↗

Summary

An upcoming clinical trial evaluating three endpoints to assess the benefit of rehabilitation in patients with advanced non-small cell lung cancer who have dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Lung Cancer (NSCLC) | Status: NOT_YET_RECRUITING